Invesco Biotechnology & Genome ETF
PBE
82 hedge funds and large institutions have $133M invested in Invesco Biotechnology & Genome ETF in 2015 Q3 according to their latest regulatory filings, with 11 funds opening new positions, 27 increasing their positions, 18 reducing their positions, and 13 closing their positions.
50% more repeat investments, than reductions
Existing positions increased: 27 | Existing positions reduced: 18
0.37% more ownership
Funds ownership: 30.5% → 30.87% (+0.37%)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
5% less funds holding
Funds holding: 86 → 82 (-4)
15% less first-time investments, than exits
New positions opened: 11 | Existing positions closed: 13
22% less capital invested
Capital invested by funds: $171M → $133M (-$38M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$2.63M |
| 2 |
FIM
Freedom Investment Management
Hartford,
Connecticut
|
+$2.05M |
| 3 |
Jane Street
New York
|
+$2.04M |
| 4 |
VKH
Virtu KCG Holdings
New York
|
+$1.59M |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$1.5M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Bank of America
Charlotte,
North Carolina
|
-$5.07M |
| 2 |
Morgan Stanley
New York
|
-$4M |
| 3 |
UBS Group
Zurich,
Switzerland
|
-$2.96M |
| 4 |
FAAS
First Allied Advisory Services
San Diego,
California
|
-$2.66M |
| 5 |
Wells Fargo
San Francisco,
California
|
-$750K |
PBE Hedge Fund Activity: Q3 2015 in Review
82 of the 3,590 institutional investors tracked by Wall St. Rank reported a position in Invesco Biotechnology & Genome ETF (PBE) for Q3 2015, worth a combined $133M — down 22% from $171M a quarter earlier.
Sellers outnumbered buyers: 13 funds closed out of PBE and 11 opened new positions — a net loss of 2 holders — while 18 trimmed existing stakes and 27 added.
The largest buyer was Susquehanna International Group, adding an estimated $2.63M. The largest seller was Bank of America, cutting an estimated $5.07M.
- 82 institutional investors held Invesco Biotechnology & Genome ETF (PBE) as of Q3 2015, down from 86 in Q2 2015.
- Funds reported $133M of Invesco Biotechnology & Genome ETF stock for Q3 2015, down 22% quarter-over-quarter.
- 11 funds opened new Invesco Biotechnology & Genome ETF positions in Q3 2015 and 13 closed out, a net change of -2 holders.
- The largest Invesco Biotechnology & Genome ETF buyer in Q3 2015 was Susquehanna International Group, an estimated $2.63M added.
- The largest Invesco Biotechnology & Genome ETF seller in Q3 2015 was Bank of America, an estimated $5.07M sold.
Based on aggregated 13F filings for Q3 2015.